Pharmacokinetics and Toxicokinetic Considerations - Vol II

Pharmacokinetics and Toxicokinetic Considerations - Vol II

Tekade, Rakesh Kumar

Elsevier Science & Technology

02/2022

814

Dura

Inglês

9780323983679

15 a 20 dias

1810

1. Basic principles and concept in Toxicokinetic
2. Factors Influencing Drug Toxicity
3. Molecular biology of apoptotic, necrotic and necroptotic cell death
4. Toxicogenomic in drug safety assessment
5. Understanding the concept of signal toxicity
6. Importance of toxicity testing
7. Methods and Models for in vitro toxicity
8. New Emerging technologies for genetic toxicity testing
9. Zebrafish models for toxicological screening
10. Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs
11. Food-Drug Interactions and their Implications on Oral Drug Bioavailability
12. Drug-Drug interactions and their implications on the Pharmacokinetics of the Drugs
13. Clinical Importance of Herb-Drug interaction
14. Insilico methods for the prediction of drug toxicity
15. Organ-on-a-chip for assessing environmental toxicants
16. Toxicity and toxicokinetics consideration in product development and drug research
17. Drug Toxicity and Forensic Pharmacokinetics
18. Excipient's toxicity and safety
19. Pharmaceutical excipients: Special focus on Adverse drug interactions
20. Emerging role of novel excipients in drug product development and their safety concerns
21. Toxicity of Pharmaceutical azo dyes
22. Environmental and Safety Aspects of Bionanotechnology
23. Toxicological Risk assessment of medical devices
24. Developmental toxicity of nanomaterials used in healthcare
25. Ethical defilements in clinical research and potential roles of Institutional review board
26. Toxicodynamic in Drug research
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?API; Adverse drug reactions; Ageing; Apoptosis; Artificial intelligence; Artificial neuronal network; Assessment; Azo dyes; Bioactivation; Bioavailability; Bioinformatics; Biomarkers; Biomarkers of diseases; Bionanotechnology; Carcinogenicity; Cell death; Clinical research; Clinical trials; Comet assay; Compartment models; Criminal investigations; Cryoprotectant toxicity; Cytotoxicity; Cytotoxicity assays; Developmental health hazards; Developmental toxicity; Disorders; Drug development; Drug exposure; Drug interaction; Drug toxicity; Drug-drug interaction; Ecological risk; Elution assay; Endocrine-disrupting chemicals; Environmental pollutant; Environmental toxicants; Ethical violation; Ethics; Excipient safety; Excipient toxicity; Excipients; Factors influencing toxicity; Fetal development; Food-drug interaction; Forensic medicine; Forensic pharmacology; Genetic toxicity; Genotoxicity; Geriatric pharmacology; Hazard identification; Hemocompatibility; Hemolysis assay; Hepatotoxicity; Herb; Herbal medicine; Human trials; IPEC; Immunotoxicity; In silico; In vitro; In vitro methods; In vitro models; In vivo; Inactive ingredient database; Institutional review board; Medications; Metabolism; Metabolites; Microbiota; Molecular mechanisms; Nanomaterials; Nanopollution; Narrow therapeutic drugs; Necroptosis; Necrosis; Nephrotoxicity; Neurotoxicity; Novel; Novel approach; Novel excipients; OSAR modeling; Organ-on-a-chip; Oxidative stress; Pediatric formulation; Pharmacodynamics; Pharmacokinetics; Physiology of the body; Polypharmacy; Polytherapy; Preclinical study; Pyrogenicity; Regulatory aspect; Regulatory guideline; Regulatory requirements; Safety; Sensitization; Signal toxicity; Specific food-drug interaction; Specimens